Table 3.

Initial acylcarnitine profile among MMA mutase, MMA cblB, PA and false positive patients

	False Positive (n = 14)	MMA		PA (n = 4)
		mut (n = 18)	cbl (n = 1)
C3	9.05 ± 2.74 (4.65~13.70)	11.21 ± 3.05 (6.30~17.52)	6	11.11 ± 2.72 (9.07~15.1)
C3:C2	0.38 ± 0.39 (0.10~1.24)	0.80 ± 0.50* (0.36~2.36)	0.43	1.54 ± 1.02* (0.60~2.97)
Average methylmalonic acid	45.25 ± 45.20 (11.69~122.30)	271.16 ± 145.59* (125.8~634)	14.8	0.97$

This table showed there is overlapping data among each group. * indicates significant difference (p < 0.05) compared to false positive group; $ indicates significant lower compared to mutase type patients. It reveals in terms of initial C3 level, PA/ mut > false; regarding to initial C3: C2, mut/PA > false/cbl; and MMA level: mut > false/cbl > PA